ASA urges CMS to preserve Medicare’s physician supervision requirement for anesthesia careNovember 22, 2026
General New dual-targeted drug receives FDA approval for head and neck cancerBy Healthcare Propulsion StaffNovember 22, 20260 On Nov. 5, the U.S. Food and Drug Administration (FDA) approved the use of a new drug to treat head…